Ocsaímorfón

Oxymorphone (also known by the brand name Opana) is a semi-synthetic opioid analgesic used in the management of moderate to severe pain, and is similar in structure to other opioids such as morphine and heroin. Oxymorphone was first developed in Germany in 1914and introduced to the American market in 1959. Unlike many other opioids, oxymorphone is almost devoid of antitussive properties.Oxymorphone is an important precursor to other opioids and opioid antagonists such as naloxone.

Also known as: Opana, Numorphan, Stop signs

Classification

Chemical: Medicine
Chemical: Morphinan
Chemical: Opioid
Psychoactive: Depressant
Tag: Habit-Forming
Tag: substituted morphinan

Effects

Pupil Constriction
Physical Euphoria
Pain Relief
Sedation
Muscle Relaxation
Itchiness
Cognitive Euphoria
Anxiety Suppression
Dizziness
Euphoria
Mood Lift
Sadness
Dulled Perception
Cognitive Dysphoria
Decreased Libido
Increased Music Appreciation
Internal Hallucination
Sound Amplification

Routes of Administration

Oral

Dosage

Heavy: 30 mg
Light: 2.5 – 10 mg
Common: 10 – 20 mg
Strong: 20 – 30 mg
Threshold: 2.5 mg

Duration

Onset: 0.33-0.75 h
After Effects: 1-12 h

Insufflated

Dosage

Heavy: 6-10 mg
Light: 2 – 4 mg
Common: 4 – 6 mg
Strong: 6 – 10 mg
Threshold: 2 mg

Duration

Onset: 0.02-0.08 h
After Effects: 1-12 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu